TRIMERIS INC
10-Q, EX-27, 2000-11-13
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: TRIMERIS INC, 10-Q, 2000-11-13
Next: HOTELWORKS COM INC, 10-Q, 2000-11-13



<TABLE> <S> <C>


<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          59,611
<SECURITIES>                                    35,416
<RECEIVABLES>                                        8
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                95,270
<PP&E>                                           8,223
<DEPRECIATION>                                   4,503
<TOTAL-ASSETS>                                 100,126
<CURRENT-LIABILITIES>                            9,084
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            16
<OTHER-SE>                                      89,543
<TOTAL-LIABILITY-AND-EQUITY>                   100,126
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                25,894
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 165
<INCOME-PRETAX>                               (21,480)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (21,480)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (21,480)
<EPS-BASIC>                                     (1.39)
<EPS-DILUTED>                                   (1.39)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission